Confirmation

Sign Out Cancel

PhenyLEPHRine

Sympathomimetic

ACP: Maintenance of blood pressure in acute hypotensive states or shock following adequate fluid volume replacement in airway management

ACP: Maintenance of blood pressure in acute hypotensive states or shock following adequate fluid volume replacement during airway management

100 mcg IV slow push every 2-5 minutes to maximum of 500 mcg
- Administer dose over 20-30 seconds

Not authorized in pediatric patients; consider the use of push-dose epinephrine

Agonizes alpha-adrenergic receptors producing arterial vasoconstriction.

Intravenous:

Exercise caution when administering phenyLEPHRine to patients with bradycardia, incomplete AV block, or other underlying cardiovascular disease.
PhenyLEPHRine carries a significant risk of sloughing and tissue necrosis if extravasation occurs. Ensure administration line is patent and free-flowing.
Rapid IV administration of phenyLEPHRine may result in the development of premature ventricular contractions, ventricular tachycardia, or hypertension.